Weight Loss Injections: What Works Now and What’s Coming Next
An evidence-based overview of approved treatments and emerging therapies for weight management.
Overview
Weight loss injections are prescription-based treatments that help regulate appetite, improve satiety, and support metabolic control. They are typically prescribed for obesity or weight-related medical conditions.
Approved Weight Loss Injections
entity[“medication”,”Semaglutide”,”GLP-1 weight loss drug”] (Wegovy)
Semaglutide is a GLP-1 receptor agonist that reduces appetite, slows digestion, and increases feelings of fullness. It is one of the most widely prescribed medications for chronic weight management.
entity[“medication”,”Tirzepatide”,”dual agonist weight loss drug”] (Zepbound)
Tirzepatide targets both GIP and GLP-1 receptors, offering enhanced appetite suppression and significant weight reduction in clinical studies.
entity[“medication”,”Liraglutide”,”GLP-1 weight loss drug”] (Saxenda)
Liraglutide is a daily injection that helps regulate hunger signals and supports gradual weight loss through appetite control.
How These Injections Work
Most modern weight loss injections function by mimicking gut hormones that signal fullness to the brain. This leads to reduced appetite, lower calorie intake, and improved blood sugar regulation.
Emerging Treatments (Not Yet Approved)
entity[“medication”,”Retatrutide”,”experimental GLP-1/GIP/glucagon agonist”]
Retatrutide is an investigational triple-hormone agonist currently in clinical trials. Early studies suggest strong weight reduction potential, but it is not yet approved for medical use or prescription.
Important: This compound is still under research and is not commercially available as an approved treatment.
Safety & Medical Disclaimer
Weight loss injections should only be used under medical supervision. This page is for informational and educational purposes only and does not constitute medical advice or promotion of unapproved medications.
Conclusion
Approved treatments like semaglutide and tirzepatide are currently the most effective and accessible options for medical weight management, while newer therapies such as retatrutide remain in development.

